Gaudium IVF and Women Health Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Gaudium IVF and Women Health Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹36 of operating cash. Lower than 85% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹36Over the last 3 years, every ₹100 of reported profit came with ₹36 of operating cash.
Lower than 85% of Healthcare companies in India.
Self-Funding Ratio
1.1×Over the last 3 years its own operating cash covered its investment spending (capex) 1.1 times.
Lower than 61% of Healthcare companies in India.
Cash Locked Ratio
₹40For every ₹100 of sales, ₹40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹1 tied up three years earlier.
More money tied up than 78% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹18Sales grew 136% in 3 years; of every extra ₹100 of sales, ₹18 became extra profit.
Higher than 52% of Healthcare companies in India.
Asset Productivity Ratio
+136% / +427%In 3 years sales changed by +136% while total assets changed by +427%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.3×Debt due within a year is covered 0.3 times by its yearly operating cash.
Lower than 77% of Healthcare companies in India.
Cash Cushion Ratio
−2%Debt, after subtracting cash, equals 2% of its market value (net debt).
Lower than 53% of Healthcare companies in India.
Tangible Assets Ratio
89%Of every ₹100 the company owns, ₹89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 71% of Healthcare companies in India.
Tangible Net Worth Ratio
86%Of every ₹100 of net worth, ₹86 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 66% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Gaudium IVF and Women Health Limited owes ₹0.21 for every ₹1 it owns. Net profit rose 28% in the year to Mar 2026, and grew 22% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
27.8Investors pay ₹27.8 for every ₹1 of Gaudium IVF and Women Health Limited's yearly profit, lower than 70% of Healthcare companies in India.
P/B ratio
4.48The share price is 4.48 times Gaudium IVF and Women Health Limited's book value per share, lower than 54% of Healthcare companies in India.
Market cap
₹683 CrThe total market value of all of Gaudium IVF and Women Health Limited's shares at today's price (share price × number of shares), smaller than 84% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹152 CrWhat Gaudium IVF and Women Health Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹20.92Net worth divided by the number of shares. The share price of ₹93.83 is 4.5 times this, which is the P/B above.
Return on equity (ROE)
13.8%Gaudium IVF and Women Health Limited earned 13.8% on its shareholders' money over the last year, higher than 55% of Healthcare companies in India.
Owes vs Owns
0.21×Gaudium IVF and Women Health Limited owes ₹0.21 for every ₹1 it owns (low), lower than 81% of Healthcare companies in India.
Dividend yield
NoneGaudium IVF and Women Health Limited does not currently pay a dividend.
Revenue growth
+48%Revenue rose 48% in the year to Mar 2026, and grew 33% a year on average over 3 years.
Profit growth
+28%Net profit rose 28% in the year to Mar 2026, and grew 22% a year on average over 3 years.
Profit margin
23.4%Gaudium IVF and Women Health Limited keeps ₹23 of every ₹100 of revenue as net profit.
Cash quality
0.3×Cash from Gaudium IVF and Women Health Limited's business was 0.3× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
10.2×Gaudium IVF and Women Health Limited's operating profit covered its interest costs 10.2 times in the year to Mar 2026.
Cash vs debt
Net debtGaudium IVF and Women Health Limited had ₹16 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Gaudium IVF and Women Health Limited's P/E ratio?
Investors pay ₹27.8 for every ₹1 of Gaudium IVF and Women Health Limited's yearly profit, lower than 70% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Gaudium IVF and Women Health Limited: ₹683 Cr ÷ ₹152 Cr (31 Mar 2026) = 4.5.
What is Gaudium IVF and Women Health Limited's return on equity?
Gaudium IVF and Women Health Limited earned 13.8% on its shareholders' money over the last year, higher than 55% of Healthcare companies in India.
How much does Gaudium IVF and Women Health Limited owe compared with what it owns?
Gaudium IVF and Women Health Limited owes ₹0.21 for every ₹1 it owns (low), lower than 81% of Healthcare companies in India.
Does Gaudium IVF and Women Health Limited pay a dividend?
No. Gaudium IVF and Women Health Limited does not currently pay a dividend.
Is Gaudium IVF and Women Health Limited's revenue growing?
Revenue rose 48% in the year to Mar 2026, and grew 33% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.